title: HIV pharmacotherapy: A review of integrase inhibitors.
abstract: Integrase strand transfer inhibitors (INSTIs) are a class of antiretroviral agents used to treat HIV. These drugs--raltegravir, elvitegravir, and dolutegravir--are preferred options for treatment-naïve patients when used in combination with two nucleoside reverse transcriptase inhibitors. Based on clinical trials, INSTIs have been proven to be effective with minimal safety concerns. This article reviews the pharmacologic profile, role in therapy, and safety and efficacy of each agent.
authors.affiliation: Elaine Wong is an associate professor of pharmacy practice at Long Island University's Arnold & Marie Schwartz College of Pharmacy and Health Sciences (LIU Pharmacy) in Brooklyn, N.Y. At the time this article was written, Nathan Trustman and April Yalong were students in the doctor of pharmacy program at LIU Pharmacy. The authors have disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Elaine
authors.initials: E
authors.lastname: Wong
authors.forename: Nathan
authors.initials: N
authors.lastname: Trustman
authors.forename: April
authors.initials: A
authors.lastname: Yalong
mesh_terms: D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000494:pharmacology*; D006575:Heterocyclic Compounds, 3-Ring / Q000494:pharmacology*; D006801:Humans; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D015363:Quinolones / Q000494:pharmacology*; D000068898:Raltegravir Potassium / Q000494:pharmacology*; D016032:Randomized Controlled Trials as Topic; D000099226:Dolutegravir
chemical_list: D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D015363:Quinolones; D000068898:Raltegravir Potassium; D000099226:Dolutegravir; C509700:elvitegravir